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 Aim: The aim of this experimental study was to examine the effect of the antioxidant drug “U-74389G”, 
on rat model and particularly in a hypoxia – reoxygenation protocol. The beneficial effect or non-
effectiveness of that molecule was studied hematologically using blood mean corpuscular hemoglobin 
(MCH) levels.  
Methods: 40 rats of mean weight 231.875 gr were used in the study. MCH levels were measured 60 min 
after reperfusion (groups A and C) and 120 min after reperfusion (groups B and D) with the administration 
of drug U-74389G in groups C and D.  
Results: The results were that U-74389G administration significantly increased the MCH levels by 
2.40% ± 0.57% (p = 0.0001). Reoxygenation time non-significantly decreased the MCH levels by 0.48% ± 
0.69 (p = 0.4103). However, U-74389G administration and reoxygenation time together significantly 
increased the MCH levels by 1.33% ± 0.36% (p = 0.0005). 
Conclusion: The results of this study indicate that U-74389G administration either alone or interacted 
with reoxygenation time has significant increasing short – term effects on the pathophysiology recovery of 
MCH values. 




Cilj: Cilj ove eksperimentalne studije je ispitati učinak antioksidantnog lijeka “U-74389G”, na model 
štakora, a posebno u protokolu hipoksije i ponovljene oksigenacije. Blagotvoran učinak ili neučinkovitost 
navedene molekule ispitani su hematološki korištenjem srednjih razina crvenih krvnih tjelešaca (MCH).  
Metode: U studiji je korišteno 40 štakora srednje težine od 231,875 g. MCH razine izmjerene su  60 min 
nakon reperfuzije (skupine A i C) i 120 min nakon reperfuzije (skupine B i D) davanjem lijeka U-74389G 
skupinama C i D.  
Rezultati: Davanje lijeka U-74389G značajno je povećalo razine MCH za 2,40% ± 0,57% (p = 0,0001). 
Ponovljena oksigenacija smanjila je beznačajno razine  MCH za 0,48% ± 0,69 (p = 0,4103). Davanje U-
74389G tijekom ponovljene oksigenacije međutim, značajno je povećalo MCH razine za 1,33% ± 0,36% (p 
= 0,0005). 
Zaključak: Rezultati ove studije pokazuju da zasebno davanje U-74389G ili u interakciji s ponovljenom 
oksigenacijom,  značajno povećava kratkotrajne učinke na oporavak patofiziološke razine  MCH. 
Ključne riječi: hipoksija U-74389G, srednja razina crvenih krvnih tjelešaca, reperfuzija 
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Circulatory hypoxia and reoxygenation (HR) 
remain one of the main causes of permanent or 
transient damage with serious implications on 
adjacent organs and certainly on patients’ health. The 
use of antioxidant substances has been a research 
subject for many years. However, even if important 
progress has been made, satisfactory answers have 
not been given yet to fundamental questions such as 
how much powerful should an antioxidant be, when it 
should be administered, and in which dosage. The 
particularly satisfactory action of the antioxidant U-
74389G in tissue protection has been noted in several 
performed experiments. After a careful literature 
search (PubMed – Medline) was conducted, it was 
realized that this certain antioxidant has been tried in 
HR experiments. However, just few relative reports 
were found, not covering completely this particular 
matter. Also, a lot of publications addressed trials of 
other similar molecules of aminosteroids (lazaroids) 
to which the studied molecule also belongs.                
U-74389G or better 21-[4-(2,6-di-1-pyrrolidinyl-4-
pyrimidinyl)-1-piperazinyl]-pregna-1,4,9(11)-triene-
3,20-dione maleate salt is an antioxidant which 
prevents both arachidonic acid-induced and iron-
dependent lipid peroxidation.
1
 It protects against 
ishemia referfusion (IR) injury in animal heart, liver, 
and kidney models. These membrane-associating 
antioxidants are particularly effective in preventing 
permeability changes in brain microvascular 
endothelial cells monolayers. The same authors
 
found 
the influence of U-74389G as depicted in Table 1 on 
some biochemic variables serum levels in related IR 
injury experi-ments, 1h, 1.5h, 2h and interaction of         




The aim of this experimental study was to 
examine the effect of the antioxidant drug          
“U-74389G” on rat model and particularly in an        
HR protocol. The beneficial effect or non-effectiveness 
of that molecule was studied by measuring blood 
mean corpuscular hemoglobin concentration (MCH) 
levels. This variable has great diagnostic value in 
anemia investigation.
3
   
 




This experimental study was laid out at                        
the Exprerimental Research Center of ELPEN 
Pharmaceuticals Co. Inc. S.A. at Pikermi, Attiki and 
by Veterinary Address of East Attiki Prefecture under 
3693/12-11-2010 & 14/10-1-2012 decisions. All 
settings needed for the study including consumables, 
equipment and substances used, were a courtesy  S. 
A. Albino female Wistar rats used in accordance with 
the accepted standards of humane animal care. They 
were housed in a laboratory 7 days before the 
experiment, having easy access to water and food. 
The experiment was acute, that is, the animal usage 
was completed by following experimental set of times 
without awakening and preservation of the rodents. 
They were randomly assigned to four experimental 
groups (10 animals in each group).  
1) Hypoxemia for 45 min followed by 
reoxygenation for 60 min (group A).  
2) Hypoxemia for 45 min followed by 
reoxygenation for 120 min (group B).  
3) Hypoxemia for 45 min followed by 
immediate U-74389G intravenous (IV) 
administration and reoxygenation for 60 min 
(group C).  
4) Hypoxemia for 45 min followed by 
immediate U-74389G IV administration and 
reoxygenation for 120 min (group D). The 
molecule U-74389G dose was 10 mg/Kg 
body weight of animals.   
 
Table 1: The U-74389G influence (±SD) on the levels of some biochemic variables concerning reperfusion 
(rep) time 




1h rep p 1.5h rep p 2h rep p 
Interaction of U-






+22.66%±12.37% 0.0663 +31.91%±7.69% 0.0001 +41.16%±9.65% 0.0003 +17.75%±4.79% 0.0005 
sodium21 +1.22%±0.66% 0.0707 +0.17%±0.61% 0.7714 -0.87%±1.03% 0.3995 -0.32%±0.36% 0.3693 
chloride22  -0.58%±0.77% 0.4533 -0.97%±0.53% 0.0879 -1.36%±0.76% 0.1113 -0.75%±0.38% 0.0159 
phosphorus23  -2.23%±5.51% 0.7966 -1.61%±3.32% 0.5789 -1%±4.48% 0.8129 -1.09%±2% 0.5771 
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The experiment started with animals submitted to 
prenarcosis followed by general anesthesia. Their 
electrocardiogram and acidometry were continuously 
monitored. Their inferior aorta was prepared so as 
their flow to be excluded by forceps. After exclusion, 
the protocol of HR was applied, exactly as described 
in experimental groups. The molecules were 
administered at the time of reoxygenation, through 
inferior vena cava after catheterization had been 
achieved. The MCH levels measurement was 
performed at 60 min of reoxygenation (groups A and 
C) and 120 min of reoxygenation (groups B and D). 
Rats were submitted to general anesthesia by 
initial intramuscular (IM) administration of 0.5 cc 
compound, which constituted of 0.25 cc xylazine, [25 
cc, 20mg/cc] and 0.25 cc ketamine hydrochloride 
[1000, 100mg/cc, 10cc]. Before the initiation of 
laparotomy, 0.03 cc butorphanol [10mg/cc, 10cc] an 
anesthetic agent was administered subcutaneously 
(SC). Continuous oxygen supply was administered 
during the whole experiment performance. 
Hypoxemia was caused by clamping inferior aorta 
over renal arteries for 45 min after laparotomic access 
was achieved. Reoxygenation was induced by 
removing the clamp and reestablishing the inferior 
aorta patency. Forty (40) female Wistar albino rats 
were used of mean weight 231.875 gr [Std. Dev: 
36.59703 gr], with min weight ≥ 165 gr and max 
weight < 320 gr. The rats’ weight could potentially be 
a confusing factor, e.g. fatter rats to have greater 




20 control rats of mean weight 252.5 gr [Std. Dev: 
39.31988 gr] were subjected to hypoxemia for 45 min 
followed by reoxygenation.  
 
Group A 
Reoxygenation which lasted 60 min concerned 10 
controls rats of mean weight 243 gr [Std. Dev: 
45.77724 gr] and post-experimental mean MCH 
levels 19.92 pgr [Std. Dev: 0.9635586 pgr] (Table 2).
     
 
Group B 
Reoxygenation which lasted 120 min concerned 
10 controls rats of mean weight 262 gr [Std. Dev: 
31.10913 gr] and post-experimental mean MCH 
levels 19.8 pgr [Std. Dev: 0.8273115 pgr] (Table 2).
   
 
Lazaroid (L) group 
20 rats of mean weight 211.25 gr [Std. Dev: 
17.53755 gr] suffered hypoxemia for 45 min followed 
by reoxygenation in the beginning of which 10 mg U-
74389G/kg body weight were IV administered.  
 
Group C 
Reoxygenation which lasted 60 min concerned 10 
L rats of mean weight 212.5 gr [Std. Dev: 17.83411 
gr] and post-experimental mean MCH levels 20.6 pgr 
[Std. Dev: 0.5715475 pgr] (Table 2).
     
 
Group D 
Reoxygenation which lasted 120 min concerned 
10 L rats of mean weight 210 gr [Std. Dev: 18.10463 
gr] and post-experimental mean MCH levels 20.29 
pgr [Std. Dev: 0.6332459 pgr] (Table 2).
   
 
Statistical analysis   
 
Every rat weight group initially was compared 
with each one of the 3 remaining groups by applying 
statistically paired t-test (Table 3).  
 
Table 2: Weight and mean MCH levels and Std. Dev. of groups  
Tablica 2. Težina i prosječna MCH razina kod standardnih devijacija skupina  
 
Group / Skupina Variable / Varijabla Mean/ Prosjek SD* 
Α Weight /težina 243 gr 45.77724 gr 
 MCH 19.92 pgr 0.9635586 pgr 
B Weight /težina 262 gr 31.10913 gr 
 MCH 19.8 pgr 0.8273115 pgr 
C Weight /težina 212.5 gr 17.83411 gr 
 MCH 20.6 pgr 0.5715475 pgr 
D Weight /težina 210 gr 18.10463 gr 
 MCH 20.29 pgr 0.6332459 pgr 
*Standard deviation / Standardna devijacija 
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Table 3: Statistical significance of mean value difference for groups after statistical paired t test application.  
Tablica 3. Statistička značajnost prosječne vrijednosti razlike kod skupina nakon primjene parnog t-testa  
 
DG* Variable / Varijabla Difference / Razlika p-value  / p-vrijednost 
Α-Β Weight /težina -19 gr 0.2423 
 MCH 0.1199995 pgr 0.3732 
Α-C Weight /težina 30,5 gr 0.0674 
 MCH -0.6800003 pgr 0.1167 
Α-D Weight /težina 33 gr 0.0574 
 MCH -0.3700003 pgr 0.3522 
Β-C Weight /težina 49.5 gr 0.0019 
 MCH -0.4899998 pgr 0.2042 
Β-D Weight /težina 52 gr 0.0004 
 MCH -0.4899998 pgr 0.2042 
C-D Weight /težina 2,5 gr 0.7043 
 MCH 0.31 pgr 0.0986 
* Difference for groups/Razlika za skupine 
 
Table 4: The increasing influence of U-74389G in connection with reoxygenation time. 




95% c. in.* 
Reoxygenation 
time / Vrijeme 
ponov. oksigen 
p-values * P-vrijednosti 
t-test glm 
0.6800003 pgr     -0.064305 pgr - 1.424306 pgr 1h 0.1167 0.0709 
0.58500005 pgr    0.1021569 pgr - 1.067843 pgr 1.5h 
§
 0.0360 0.0189 
0.4899998 pgr    -0.2021718 pgr - 1.182171 pgr 2h 0.2042 0.1542 
 
*95% confidence interval / Razmak povjerljivosti 
§ Reoxygenation endpoint representative of the total experiment / Predstavnik krajnje točke cijelog eksperimenta 
ponovljene oksigenacije  
 
Any emerging significant difference among MCH 
levels will be investigated whether owed to the above 
mentioned probable significant weight correlation. 
Every rat MCH group was initially compared with 
another from the 3 remaining groups by applying 
statistically paired t-test (Table 3). The application of 
generalized linear models (glm) with dependant 
variable of MCH levels and independent variables of 
U-74389G administration or not, reoxygenation time 
and their interaction, resulted in: U-74389G 
administration significantly increased the MCH levels 
by 0.58500005 pgr [0.1021569 pgr - 1.067843 pgr]  
(p = 0.0189). This finding was in accordance with the 
result of paired t-test (p = 0.0360). Reoxygenation 
time non-significantly increased the MCH levels by 
0.2149998 pgr  [-0.7298397 pgr - 0.2998401 pgr]              
(p = 0.4032), also in accordance with paired t-test             
(p = 0.0551). However, U-74389G administration and 
reoxygenation time together non-significantly 
increased the MCH levels by 0.2627273 pgr [-
0.038527 pgr - 0.5639815 pgr] (p = 0.0855). 
Reviewing the above and Table 3, Table 4 sums up 
concerning the increasing influence of U-74389G  in 
connection with reoxygenation time. Inserting the 
rats’ weights also as an independent variable at 
generalized linear models analysis, a significant 
relation results in (p = 0.0004), so further 
investigation is needed among predicted values of 
MCH corrected for rats' weights. The predicted MCH 
values were calculated for every rat (Table 5). The 
statistically paired t-test appliance among all groups 
for predicted MCH values was revealed in Table 6 
and also glm with dependant variable number of 
predicted MCH levels and independent variables of 
U-74389G administration or none, reoxygenation 
time and their interaction were again applied.   
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Table 5: The predicted mean MCH values for every 
group  








A 20.02206 pgr 0.5367315 pgr 
B 19.79929 pgr 0.3647491 pgr 
C 20.37967 pgr 0.2090994 pgr 
D 20.40898 pgr 0.2122739 pgr 
 








Regarding predicted MCH values: U-74389G 
administration significantly increased the predicted 
MCH levels by 0.4836479 pgr [0.255143 pgr - 
0.7121529 pgr] (p = 0.0001). This finding was in 
accordance with the results of paired t-test (p = 
0.0002). Reoxygenation time non-significantly 
decreased the predicted MCH by 0.0967295 pgr  
Table 6: Statistical significance of mean predicted 
MCH values difference for groups after statistical 
paired t test application  
Tablica 6. Statističko značenje prosječnih predviđenih 
MCH vrijednosti za skupine nakon primjene 




p-value   
p-vrijednost 
Α-Β 0.2227711 pgr 0.2423 
Α-C -0.357604  pgr 0.0674 
Α-D -0.3869175  pgr 0.0574 
Β-C -0.5803751  pgr 0.0019 
Β-D -0.6096886 pgr 0.0004 
C-D -0.0293135 pgr 0.7042 
 
*Difference for groups / Razlika za skupine 
 
[-0.3731936 pgr - 0.1797346 pgr] (p = 0.4831) also in 
accordance with paired t-test (p = 0.3375). However, 
U-74389G administration and reoxygenation time 
together significantly increased the MCH levels by 
0.2691374 pgr [0.1264887 pgr - 0.4117862 pgr] (p = 
0.0005). Reviewing the above and Table 6, Tables 7 
and 8 sum up concerning the increasing influence      
of U-74389G in connection with reoxygenation         
time. 
   
Table 7: The predicted increasing influence of U-74389G in connection with reoxygenation time 




95% c. in.* Reoxygenation time / 
Vrijeme ponov. oksigen 
p-values * p-vrijednosti 
t-test glm 
+0.357604  pgr -0.0250888 pgr - 0.7402968 pgr 1h 0.0674 0.0653 
+0.4836463 pgr    0.255143 pgr - 0.7121529 pgr 1.5h 
§
 0.0002 0.0001 
+0.6096886 pgr    0.3293102 pgr - 0.8900669 pgr 2h 0.0004 0.0002 
-0.0967295 pgr   -0.3731936 pgr - 0.1797346 pgr   reoxygenation time / 
vrijeme ponov. oksigen 
0.4831 0.3375 
+0.2691374 pgr 0.1264887 pgr - 0.4117862 pgr interaction / interakcija 0.0005  
 
* 95% Confidence interval / 95% Razmak povjerljivosti 
§ Reoxygenation endpoint representative of the total experiment / Krajnje točke ponovljene oksigenacije cijelog eksperimenta  
 
Table 8. (%) predicted increasing influence of U-74389G in connection with reoxygenation time 
Tablica 8. Postotak predviđenog rastućeg utjecaja U-74389G povezan s vremenom ponovljene oksigenacije 
 
Alteration / Promjena ±SD
*
 Reoxygenation time / Vrijeme pon. oksigenacije p-values / p-vrijednosti 
1.77% ±0.96% 1h 0.0663 
2.40% ±0.57% 1.5h 
§
 0.0001 
3.03% ±0.71% 2h 0.0003 
-0.48% ±0.69% reoxygenation time / vrijeme ponov. oksigen 0.4103 
1.33% ±0.36% Interaction / interakcija 0.0005 
*Standard deviation / Standardna devijacija 
§ Reoxygenation endpoint representative of the total experiment / Krajnje točke ponovljene oksigenacije cijelog eksperimenta  





Low MCH production is not only being influenced 
by hypoxemia but also may induce it, and particularly 
by certain mode, as the next clinical situations show. 
Aikimbaev K. et al
4
 significantly related the reduced 
(p < 0.0001) blood flow velocities and respective 
MCH levels (p < 0.04) of the central retinal artery and 
the markedly higher resistance and pulsatility index 
values (p < 0.02 and p < 0.03) in sickle cell patients 
compared with control ones.  Wilke A. et al
5
 removed 
an intestine leiomyoma which led to chronic anemia 
with a conspicuous MCH level of 20 pgr and 
additionally to angina pectoris. After the removal and 
normalization of hemoglobin this patient was 
symptom free. Anemia as possible and unique cause 
of angina pectoris ought to be verified. Wolf PL et al
6
 
found MCH levels modestly decreased over a 10-
month period prior to Olympic Trials in male distance 
runners. The cause of runners’ anemia had been 
demonstrated due to hematuria and ischemia of the 
intestinal mucosa with bleeding. Gorokhova SG et al 
showed
7
 significantly lower indices of MCH levels, 
more frequent anemia by 1.25 times (p < 0.01), also 
correlated (p < 0.01) with depression of ST segment, 
more frequent ischemic changes on ECG, less 
exercise tolerance, high ectopic activity and more 
severely affected coronary circulation angiography in 
type 2 diabetic mellitus (DM) ischemic heart disease 
(IHD) patients than non-DM IHD ones. Waheed N et 
al found febrile seizures
8
 more common between the 
ages of 12 months to 36 months old, with 5.3% of 
them being iron deficient. Mean MCH levels were 
27.11 ± 3.28 and mean ferritin levels were 66.57 ± 
24.7 in children of 6 months to 5 years old, admitted 
with fever and seizures. Iron status has no role in 
febrile seizures. Liu B et al treated the underground 
Mandarin vole (Lasiopodomys mandarinus) and 
Kunming (KM) mouse (Mus musculus)
9
 with chronic 
intermittent hypoxia (10.0% oxygen), for 4 weeks 
showing that MCH levels in the Mandarin vole were 
significantly lower than those in the KM mouse. 
MCH content in KM mouse was increased, while 
only MCH was increased in the Mandarin vole 
suggesting that the adaptive mechanism of the blood 
system in the Mandarin vole responds to hypoxic 
conditions differently from that of the KM mouse. 
Liu B et al showed
10
 that both rodents, the under-
ground Mandarin vole (Lasiopodomys mandarinus) 
and Kunming mouse (Mus musculus) (KM) under 
chronic normobaric hypoxic treatment (10.0% O(2), 4 
w) responded to chronic hypoxia mainly by 
increasing MCH levels, though the KM mouse 
responded more acutely. Shah SL et al caused
11
 a 
significant increase in MCH levels administering 
300/48, 30/504, 75/504 lead doses, while the 75/96 
dose caused a significant decrease in Tinca tinca. 
These alterations were attributed to direct or feedback 
responses of structural damage to RBC membranes 
resulting in hemolysis and impairment in hemoglobin 
synthesis, stress related release of RBCs from the 
spleen and hypoxia, induced by exposure to lead. 
Achermann R et al significantly correlated MCH 
levels with several oxygen parameters like mean 
pO2
12
 being 9.6 mmHg and hypoxia which exists in 
spontaneous canine soft tissue sarcomas. Garruto RM 
et al showed
13
 a slight but significant increase of 
MCH values with age in children and adolescents in 
male Quechua children and adults. Armitage KB. et  
al determined
14 
MCH levels as adaptive to 
environmental factors such as hypoxia of burrows, 
high altitude, temperature and metabolic rate in a 
population of Marmota flaviventris over a period of 
seven years. Pearson TC et al raised
15
 whole-blood 
viscosity exponentially with decreasing MCH levels 
showing to be a function of it, when the samples were 
adjusted to a standard Hb concentration of 14 g/dl, in 
polycythaemia patients treated by venesection and not 
due to hypoxia. Hutton RD  increased
16
 oxygen 
availability to the tissues treating coexisting iron 
deficiency. Values for whole blood viscosity can         
be derived from the peripheral blood MCH in 
polycythemic patients secondary to hypoxia.   
Unpleasantly, references relating to U-74389G 
and MCH were not found. So, other references 
showing the general role of U-74389G were retrieved. 
Horáková L et al
17
 used brain homogenate as a model 
system to study antioxidant properties of U-74389G 
under oxidative stress. Oxidative stress was induced 
by Fe/ascorbate system and lipid peroxidation as well 
as protein modification. Thiobarbituric acid reactive 
substances were used as a marker of lipid 
peroxidation. The preventive effect concerning lipid 
peroxidation decreased by U-74389G (160 IC50 in 
μmol/l). Nediani C et al
18
 proved that 21-amino-
steroids (lazaroids) have beneficial effects in various 
pathological conditions due to their action as free 
radical scavengers and as membrane stabilizers. They 
explored the effectiveness of one of these compounds, 
U-74389G, in protecting pigs myocardium against 
ischemia reperfusion (IR) damage induced by 
transient coronary occlusion in a dose of (4 mg/kg) 
before coronary reperfusion. All these alterations 
were attenuated by aminosteroid treatment. The 
biochemical changes in adenine nucleotides and 
nucleosides levels, thus the reduction of energy 
charge, were reversed in the treated group. 
Myocardial concentration of malondialdehyde, which 
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was undetectable in the control group, was raised in 
all the animals after reperfusion, but this effect was 
significantly less marked with aminosteroid 
treatment. In addition, the higher myocardial content 
of ascorbic acid and the reduced serum potential 
peroxidation exhibited by the treated animals 
compared with untreated group indicate an enhanced 
antioxidant protection induced by aminosteroid 
administration. The conclusion is that aminosteroid 
treatment is effective in reducing the morphological 
and biochemical alterations occurring in IR 
myocardium. Perna AM et al
19
 found lipid 
peroxidation as an important factor contributing to 
tissue damage in IR syndromes. They investigated 
whether the compound U-74389G, plays a significant 
role in protecting Wistar rats heart muscle from IR 
damage. The typical morphological aspects of 
lipoperoxidative injury were shown in hearts 
transplanted without treatment: swollen mitochondria 
with disrupted cristae, damaged endothelial cells with 
the nucleous bulging into the lumen and a 
discontinued endothelial lining with diffuse edema 
among the fibers. Lazaroid treatment attenuated most 
of these damages in hearts. As for the biochemical 
findings, serum creatine kinase activity was lower in 
treated by U-74389G than in those untreated (p < 
0.05). Taken together, all these results indicate that U-
74389G treatment is effective in protecting cardiac 




U-74389G administration either alone or 
interacted with reoxygenation time has significant 
increasing short – term effects on the pathophysiology 
recovery of MCH values. It is concluded that the 
specific antioxidant action of U-74389G releases 
some anabolic action on MCH levels. U-74389G 
remains to be tested within human clinical trials with 
greater samples. Also a molecular investigation is 
required connecting both the antioxidant and anabolic 
capacities of the drug.    
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